Search results
Praluent vs. Repatha: Similaries and Differences
Verywell Health via Yahoo News· 3 months agoPraluent and Repatha are PCSK9 inhibitors that can lower low-density lipoprotein (LDL, or "bad") cholesterol levels in certain people. Though similar,...
New medication given every 1-3 months may slash stubborn high cholesterol
NewMediaWire via Yahoo Finance· 7 months agoResearch Highlights: While currently available PCSK9 inhibitor medications to lower cholesterol must...
Pharma Stock Roundup: LLY's Alzheimer's Study Setback, FDA Updates for SNY, MRK
Zacks via Yahoo Finance· 1 year agoThis week, Eli Lilly’s LLY candidate, solanezumab, failed to prevent Alzheimer’s in a study. Merck’s...
How Gene Editing Could Help Solve the Problem of Poor Cholesterol
Time via Yahoo News· 1 year agoCredit - vchal—Getty Images Cardiovascular disease is the leading cause of death in the U.S. and...
Could This Be Merck's Next Blockbuster Drug?
Motley Fool· 1 year agoEarlier this month, Merck (NYSE: MRK) announced positive results from a clinical trial of its cholesterol-lowering drug candidate MK-0616. With the...
Merck (MRK), Eisai to End Keytruda-Lenvima Combo Cancer Study
Zacks via Yahoo Finance· 9 months agoWith the phase III LEAP-010 study failing to show an overall survival benefit for patients with...
Here’s an Alternative to Statins for Lowering Cholesterol
Time via Yahoo News· 1 year agoCredit - Getty Images Statins have revolutionized heart disease by lowering cholesterol...
Amgen (AMGN) Olpasiran Lowers Lipoprotein Levels in Phase II
Zacks via Yahoo Finance· 2 years agoAmgen's (AMGN) olpasiran, a small interfering RNA molecule, is designed in such a way that it lowers...
Researchers developed a gene-editing technology that reduces 'bad' cholesterol
Engadget· 6 months agoIn a trial run by Verve Therapeutics, a Cambridge–based biotech company, researchers discovered that...
Promising drug could provide alternative to statins, new study finds
CBS News via Yahoo News· 1 year agoA new study has found that a drug could replace statins for those who cannot tolerate them, a...